Chimerix, Inc.

309 articles about Chimerix, Inc.

• Chimerix, Inc. Completes Phase I Study and Initiates a Phase II Multi-dose Clinical Trial for CMX001

  1/6/2009

• Chimerix, Inc. Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer

  1/3/2008

• Chimerix, Inc. Initiates a Multi-dose Clinical Trial of the Company's Lead Compound, CMX001, for the Treatment for Smallpox Infection

  12/11/2007

• Chimerix, Inc. Raises $23.1 Million To Advance Antiviral Drug Pipeline

  2/23/2007

• Chimerix, Inc. Announces Initiation Of Phase I Clinical Trials Of CMX001, An Oral Treatment For Smallpox Infection

  6/28/2006

• Chimerix, Inc. Acquires Lead Compound Library Of Antiviral Agents From University of Michigan

  5/24/2006

• Chimerix, Inc. And USAMRIID Collaborate To Complete Preclinical Development Of Smallpox Therapeutic

  4/18/2006

• Chimerix, Inc. Announces Selection As A Top 5 Nominee For 2005 World Technology Award In Health and Medicine

  11/10/2005

• Chimerix, Inc. Supports Biodefense Legislation To Accelerate And Innovate Counterterrorism Products

  11/3/2005